References
- Anglada A, Marquez M, Sacristan A, Ortiz J A. Inhibitors of gastric acid secretion: N-sulphonyl formamidines in a series of new histamine H2-receptor antagonists. Eur J Med Chem 1988; 23: 97–100
- Konturek S J, Brzozowski T, Drozdowicz D, Majka J. Ebrotidine, a novel H2-receptor antagonist with local gastroprotective activity. Eur J Gastroenterol Hepat 1991; 3: 941–7
- Konturek S J, Mach T, Konturek J W, Bogdal J, Stachura J. Comparison of sucralfate and ranitidine in gastroprotection against alcohol in humans. Am J Med 1989; 86(6A)55–9
- Tarnawski A, Hollander D, Stachura J, Klimczyk B, Mach B, Bogdal J. Alcohol injury to the normal human gastric mucosa; endoscopic, histologic and functional assessments. Clin Invest Med 1987; 10: 259–63
- Savarino V, Mela G S, Scalahrini P, et al. Continuous 24 hour intragastric pH monitoring: focus on reproducibility in duodenal ulcer patients. Gastroenterol Clin Biol 1986; 10: 826–30
- Savarino V. Continuous intragastric pH monitoring a real progress in the assessment antisecretory drugs. Ital J Gastroenterol 1990; 22: 20–3, Suppl 2
- Konturek S J, Kwiecien N, Obtulowicz W, et al. Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation. Gut 1979; 20: 875–81
- Ress W DW, Rhodes J, Mil Wheeler, Meek M E, Newcombe R G. Role of histamine receptors in the pathophysiology of gastric mucosal damage. Gut 1977; 72: 67–71
- Bommelaer G, Gut P H. Protection by histamine receptor antagonists and prostaglandin against gastric mucosal barrier disruption in the rat. Gastroenterology 1979; 77: 303–8
- Okabe S, Takeuchi K, Urushidani T, Takagi K. Effects of cimetidine, a histamine H2-receptor antagonists, on various experimental gastric and duodenal ulcers. Am J Dig Dis 1977; 22: 677–81
- Miyata K, Kamoto T, Nishida A, Honda K. Studies on the mechanism for the gastric mucosal protection by famotidine in rats. Jpn J Pharmacol 1991; 55: 211–22
- Robert A, Nezamis J E, Lancaster C, Hanchar A J. Cyto-protection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 1979; 77: 433–43
- Tarnawski A, Hollander D, Gergely H, Stachura J. Comparison of antacid, sucralfate, cimetidine and ranitidine in protection of the gastric mucosa against ethanol injury. Am J Med 1985; 79: 19–23, Suppl 26
- Piotrowski J, Yamaki K, Morita M, Slomiany A, Slomiany B L. Ebrotidine—a new H2-receptor antagonist with mucosal strengthening activity. Biochem Int 1992, In press
- Tarnawski A, Hollander D, Stachura J, Klimczyk B, Mach T, Bogdal J. Prostaglandin protection of the human gastric mucosa against alcohol-induced injury. Endoscopic histologic and functional assessment. Scand J Gastroenterol 1986; 21: 165–9, Suppl 125
- Agrawal N M, Godiwala T, Arimura A, Dajani E Z. Cytoprotection by a synthetic prostaglandin antagonist against ethanol-induced gastric mucosa damage, a double-blind endoscopic study in human subjects. Gastrointest Endosc 1986; 32: 67–70
- Robert A. Cytoprotection. Gastric cytoprotection. A clinical guide, D Hollander, A S Tarnawski. Plenum Medical Books, New York 1989; 3–12